US Patent 8003617 Methods of treating diabetes mellitus
Patent 8003617 was granted and assigned to Genzyme on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+155 characters)
Article
Patent abstract
The invention provides methods of treating a diabetic subject comprising administering a glucosylceramide synthase inhibitor to the subject.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Hongmei Zhao0
Nelson S. Yew0
Ronald K. Scheule0
Seng H. Cheng0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08003617 Methods of treating diabetes mellitus US Patent 8003617 Methods of treating diabetes mellitus
Infobox
Patent Number
080036170
Patent Number
80036170
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080036170
Date of Patent
August 23, 2011
0Patent Application Number
116672240
Date Filed
November 9, 2005
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08003617 Methods of treating diabetes mellitus
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08003617
Date of patent
August 23, 2011
Patent application number
11667224
Date Filed
November 9, 2005
Patent primary examiner
Find more entities like US Patent 8003617 Methods of treating diabetes mellitus
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
